Last reviewed · How we verify
peri-articular infiltration
The peri-articular infiltration is a procedure developed by the University of Warwick for the treatment of musculoskeletal conditions. It involves injecting a therapeutic agent directly into the tissues surrounding a joint to reduce inflammation and pain. The technique is not yet approved by the FDA, but it shows promise in clinical trials for conditions such as osteoarthritis and tendinitis. The procedure is minimally invasive and can be performed in an outpatient setting, making it a potentially attractive option for patients seeking non-surgical treatments. However, more research is needed to establish its long-term efficacy and safety.
At a glance
| Generic name | peri-articular infiltration |
|---|---|
| Sponsor | University of Warwick |
| Drug class | Corticosteroids and local anesthetics |
| Target | Synovial membrane and surrounding soft tissues |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
Pipeline indications
Common side effects
Key clinical trials
- Evolution of Post-Stroke Shoulder Pain With a Capsular Pattern With Physiotherapy Alone Versus Coupled With Mild Arthrographic Distension With Cortisone (PHASE4)
- Combination of Fluoroscopy and Ultrasonography Guidance in Sacroiliac Joint Injections. A Randomised Controlled Trial (NA)
- Arthroscopic Treatment of Acetabular Labral Lesions: Intrarticular Injection of Bone Marrow vs Hip Arthroscopy Alone (NA)
- Treatment of Osteoarthritis of the Hip Joint With Intra-articular Injection of Microfractured Autologous Adipose Tissue Containing Mesenchymal Stromal Cells. (NA)
- Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis (NA)
- Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Shoulder Osteoarthritis(OA) (NA)
- Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA) (NA)
- Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Hip Osteoarthritis(OA) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- peri-articular infiltration CI brief — competitive landscape report
- peri-articular infiltration updates RSS · CI watch RSS
- University of Warwick portfolio CI